Filana Therapeutics, Inc. Share-based Payment Arrangement, Accelerated Cost
Filana Therapeutics, Inc. (FLNA) reported Share-based Payment Arrangement, Accelerated Cost of $1.80 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2013-02-08
- Filana Therapeutics, Inc. share-based payment arrangement, accelerated cost for fiscal 2012 was $1.80M.
- Filana Therapeutics, Inc. share-based payment arrangement, accelerated cost for fiscal 2010 was $14.80M.
| Period end | Share-based Payment Arrangement, Accelerated Cost 12 month |
|---|---|
| 2012-12-31 | $1.80M 10-K · filed 2013-02-08 |
| 2010-12-31 | $14.80M 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |